Age and smoking predict antibody titers after the BNT162b2 COVID-19 vaccine

被引：2
|
作者：
O'Rourke, Kate
机构：
来源：
CANCER | 2022年 / 128卷 / 03期
关键词：
D O I：
10.1002/cncr.34082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：431 / 431
页数：1
相关论文
共 50 条
  • [31] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Lamb, Yvette N.
    DRUGS, 2021, 81 (04) : 495 - 501
  • [32] Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine
    Lopez-Valle, Alba
    Falkenhain-Lopez, Daniel
    Arranz, Celia R.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (07) : 891 - 892
  • [33] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Polack, Fernando P.
    Thomas, Stephen J.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Perez, John L.
    Perez Marc, Gonzalo
    Moreira, Edson D.
    Zerbini, Cristiano
    Bailey, Ruth
    Swanson, Kena A.
    Roychoudhury, Satrajit
    Koury, Kenneth
    Li, Ping
    Kalina, Warren V.
    Cooper, David
    Frenck, Robert W., Jr.
    Hammitt, Laura L.
    Tureci, Ozlem
    Nell, Haylene
    Schaefer, Axel
    Unal, Serhat
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27): : 2603 - 2615
  • [34] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Wang, Xiang
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1577 - 1578
  • [35] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine
    Tumminia, Andrea
    Romano, Marcello
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 191 - 191
  • [36] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Yvette N. Lamb
    Drugs, 2021, 81 : 495 - 501
  • [37] More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
    Walter, Emmanuel B.
    Talaat, Kawsar R.
    Gurtman, Alejandra
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (12): : 1191 - 1193
  • [38] Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
    Walter, E. B.
    Talaat, K. R.
    Sabharwal, C.
    Gurtman, A.
    Lockhart, S.
    Paulsen, G. C.
    Barnett, E. D.
    Munoz, F. M.
    Maldonado, Y.
    Pahud, B. A.
    Domachowske, J. B.
    Simoes, E. A. F.
    Sarwar, U. N.
    Kitchin, N.
    Cunliffe, L.
    Rojo, P.
    Kuchar, E.
    Ramet, M.
    Munjal, I
    Perez, J. L.
    Frenck, R. W., Jr.
    Lagkadinou, E.
    Swanson, K. A.
    Ma, H.
    Xu, X.
    Koury, K.
    Mather, S.
    Belanger, T. J.
    Cooper, D.
    Tureci, O.
    Dormitzer, P. R.
    Jansen, K. U.
    Gruber, W. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (01): : 35 - 46
  • [39] BNT162b2 boosted neutralizing antibody titers after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination
    Hammerschmidt, S. I.
    Barros-Martins, J.
    Cossmann, A.
    Ramos, G. Morillas
    Stankow, M. V.
    Odak, I.
    Dopfer-Jablonka, A.
    Hetzel, L.
    Koehler, M.
    Patzer, G.
    Binz, C.
    Ritter, C.
    Friedrichsen, M.
    Schultze-Florey, C.
    Ravens, I.
    Willenzon, S.
    Bubke, A.
    Ristenpart, J.
    Janssen, A.
    Ssebyatika, G.
    Kraehling, V.
    Bernhardt, G.
    Hoffmann, M.
    Poehlmann, S.
    Krey, T.
    Bosnjak, B.
    Foester, R.
    Behrens, G. M. N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 154 - 155
  • [40] Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine
    Levy, Itzchak
    Levin, Einav Gal
    Olmer, Liraz
    Regev-Yochay, Gili
    Agmon-Levin, Nancy
    Wieder-Finesod, Anat
    Indenbaum, Victoria
    Herzog, Karin
    Doolman, Ram
    Asraf, Keren
    Halperin, Rebecca
    Lustig, Yaniv
    Rahav, Galia
    VACCINES, 2022, 10 (08)
12345